The similarities in the clinicopathologic features between the previously reported cases and our patient suggested that patients with SRF-NCOA1/2 fusion genes might comprise a unique rhabdomyosarcoma subtype. This evidence concerns the gene NCOA1 and rhabdomyosarcoma.